Serial Number
79387355
Owner
Bicycletx LimitedAttorney
Christina M. LicursiFiling Date
Dec 4, 2023
DURAVELO Trademark
Serial Number: 79387355 • Registration: 7749218
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.
600 Atlantic Avenue
Boston, MA 02210
United States
Trademark Details
Filing Date
December 4, 2023
Registration Date
April 8, 2025
Published for Opposition
February 18, 2025
Goods & Services
Medical research services, namely, scientific, clinical, and pharmacological medical research services; scientific research for medical purposes in the field of cancerous diseases; scientific and technological services, namely, scientific research and analysis and providing scientific research information in the field of oncology for both solid and liquid tumors, urological and renal diseases, and the treatment of solid mass cancers, namely, bladder and urothelial cancer, non-small cell lung cancer, head and neck squamous cell carcinoma, pancreatic cancer, ovarian cancer, esophageal cancer, prostate cancer, cervical cancer, breast cancer, penile and anal cancer, gastric cancer, and colorectal cancer; medical and scientific research, namely, conducting clinical trials for others; medical research, namely, conducting medical trials; providing of medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research in the field of oncology
Pharmaceutical products, namely, pharmaceutical preparations for use in oncology; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology for the treatment of both solid and liquid tumors; pharmaceutical preparations for the treatment of urological and renal diseases; pharmaceutical preparations for the treatment of solid mass cancers, namely, bladder and urothelial cancer, non-small cell lung cancer, head and neck squamous cell carcinoma, pancreatic cancer, ovarian cancer, esophageal cancer, prostate cancer, cervical cancer, breast cancer, penile and anal cancer, gastric cancer, and colorectal cancer; pharmaceutical preparations for use as diagnostics, namely, diagnostic preparations for medical use and for use as clinical imaging agents